First-in-human assessment of PRX002, an anti--synuclein monoclonal antibody, in healthy volunteersMOVEMENT DISORDERSIF7.62016-11-25204OAAI
CLINICAL AND PRECLINICAL ASSESSMENT OF THE ANTI-MCAM MONOCLONAL ANTIBODY PRX003, A POTENTIAL NOVEL TREATMENT FOR TH17-MEDIATED INFLAMMATORY DISEASESANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-010PREAI
Discovery of (R)-4-Cyclopropyl-7;8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): Metabolically Stable γ-Secretase Inhibitors that Selectively Inhibit the Production of Amyloid-β over NotchJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-06-2029PRE
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's diseaseALZHEIMERS RESEARCH & THERAPYIF7.62010-12-2946OAAI
Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substanceREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52008-08-0115PREAI